Study for ELNEC 4: Symptom Management in Palliative Care Test with flashcards and multiple choice questions. Hints and explanations included! Get ready for your exam!

Multiple Choice

Which statement about pharmacologic management of dyspnea is accurate?

Opioids are the cornerstone of pharmacologic management for dyspnea in palliative care because they reduce the brain’s perception of breathlessness and blunt the ventilatory response to carbon dioxide. At low, titrated doses, they can relieve the sensation of air hunger and anxiety without meaningfully impairing gas exchange or shortening life expectancy. This makes them effective for diverse causes of dyspnea and often improves overall comfort and quality of life. Antihistamines are not the primary treatment for non-allergic dyspnea; they don’t address the central sensation of breathlessness and can cause sedation or other unwanted effects. Corticosteroids aren’t universally contraindicated and can be useful for dyspnea related to specific inflammatory or obstructive processes, but they’re not the general first-line approach for dyspnea in most palliative scenarios.

Opioids are the cornerstone of pharmacologic management for dyspnea in palliative care because they reduce the brain’s perception of breathlessness and blunt the ventilatory response to carbon dioxide. At low, titrated doses, they can relieve the sensation of air hunger and anxiety without meaningfully impairing gas exchange or shortening life expectancy. This makes them effective for diverse causes of dyspnea and often improves overall comfort and quality of life.

Antihistamines are not the primary treatment for non-allergic dyspnea; they don’t address the central sensation of breathlessness and can cause sedation or other unwanted effects. Corticosteroids aren’t universally contraindicated and can be useful for dyspnea related to specific inflammatory or obstructive processes, but they’re not the general first-line approach for dyspnea in most palliative scenarios.